From circadian rhythms to cancer chronotherapeutics (Q34606456)

3 August 2017

1 reference

title

From circadian rhythms to cancer chronotherapeutics (English)

1 reference

3 August 2017

0 references

Francis Lévi

1

1 reference

PubMed ID

11962669

3 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Chronobiology International

3 August 2017

1 reference

3 August 2017

19

1 reference

3 August 2017

1

1 reference

3 August 2017

1-19

1 reference

Molecular bases for circadian clocks

3 August 2017

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Interacting molecular loops in the mammalian circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Multilevel regulation of the circadian clock

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Genetics of the mammalian circadian system: Photic entrainment, circadian pacemaker mechanisms, and posttranslational regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Melatonin's role in vertebrate circadian rhythms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

21 January 2018

Circadian cancer therapy

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian rhythms and cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian chronotherapy for human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Increased Tolerance of Leukemic Mice to Arabinosyl Cytosine with Schedule Adjusted to Circadian System

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Toward a chronotherapy of neoplasia: Tolerance of treatment depends upon host rhythms

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Tumor-based rhythms of anticancer efficacy in experimental models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Pharmacological effects of vinorelbine on body temperature and locomotor activity circadian rhythms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Changing the dosing schedule minimizes the disruptive effects of interferon on clock function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

A serum shock induces circadian gene expression in mammalian tissue culture cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Ultradian mitotic rhythms in culture of human sarcomatous bone cells originating from the patient before and after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian rhythms of DNA synthesis in nasopharyngeal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Chronobiology of the mammalian response to ionizing radiation. Potential applications in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Rhythms in human bone marrow and blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Rhythms in human gastrointestinal mucosa and skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian variation in the expression of cell-cycle proteins in human oral epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian-system alterations during cancer processes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

The importance of dose intensity in chemotherapy of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Period shift induction by intermittent stimulation in a Drosophila model of PER protein oscillations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Time-patterned drug administration: insights from a modeling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Clinical pharmacokinetics of 5-fluorouracil with consideration of chronopharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Chronotherapy with 5-fluorouracil and folinic acid in advanced colorectal carcinoma. Results of a chronopharmacologic phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Chronomodulated chemotherapy and irradiation: an idea whose time has come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Chronotherapy of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian concepts in normal and neoplastic breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian chemotherapy for gynecological and genitourinary cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Sequential chemotherapy and circadian rhythm in human solid tumours. A randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Chronobiological concepts underlying the chronotherapy of human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Chronomodulated chemotherapy: clinical value and possibilities for dissemination in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Pharmaco-economic comparative evaluation of combination chronotherapy vs. standard chemotherapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Quality of life and chronotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Incidence of cancer among commercial airline pilots

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Light in the built environment: potential role of circadian disruption in endocrine disruption and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Night shift work, light at night, and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Rotating night shifts and risk of breast cancer in women participating in the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian rhythm of hepatic uridine phosphorylase activity and plasma concentration of uridine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian rhythm of orotate phosphoribosyltransferase, pyrimidine nucleoside phosphorylases and dihydrouracil dehydrogenase in mouse liver. Possible relevance to chemotherapy with 5-fluoropyrimidines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian variation in cell division of the mouse alimentary tract, bone marrow and corneal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circannual variation of intestinal cell proliferation in BDF1 male mice on three lighting regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

In-vitro circadian rhythm of murine bone marrow progenitor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. American Sleep Disorders Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

The difference between activity when in bed and out of bed. I. Healthy subjects and selected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Chronopharmacokinetics. Current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian time dependence of cisplatin urinary kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Infusions of fluorouracil and leucovorin: effects of the timing and semi-intermittency of drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Circadian timing of cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Contribution of the rest-activity circadian rhythm to quality of life in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Diurnal cortisol rhythm as a predictor of breast cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Maintenance chemotherapy for childhood acute lymphoblastic leukaemia: better in the evening

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia. Nordic Society for Pediatric Hematology and Oncology (NOPHO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

DNA synthetic activity in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCBI-120002676

21 January 2018

Identifiers

DOI

10.1081/CBI-120002676

1 reference

3 August 2017

1 reference

PubMed ID

11962669